Curie Brief
Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.

Pain in inflammatory myopathies runs the gamut from localized flare-driven discomfort to widespread fibromyalgia-like symptoms, according to a new survey analysis. Researchers identified four distinct pain phenotypes among 426 patients, with nearly 93% of the most severe group meeting fibromyalgia criteria. The findings could reshape how clinicians approach pain management in this complex disease.
Pain in inflammatory myopathies (IIM) is far more varied than previously appreciated. A new study published in Arthritis Care & Research used survey data from 426 patients to identify four distinct pain phenotypes — ranging from localized, flare-driven nociceptive pain to widespread, constant fibromyalgia-like symptoms. The analysis drew on responses collected through patient organizations across the US, Australia, and Canada, with dermatomyositis being the most common IIM subtype represented.
The four classes paint a nuanced picture: Class 1 (20.2% of patients) showed classic disease-related pain concentrated in the proximal limbs and closely tied to flares. Classes 2 and 3 (about 63% combined) fell in the middle, with regional pain patterns and moderate fibromyalgia overlap — roughly 70% in each group met fibromyalgia criteria. Class 4 (16.9%) was the most severe, with pain spanning all extremities and axial regions, and nearly 93% meeting fibromyalgia criteria.
By the Numbers:
Why it matters: These findings challenge a one-size-fits-all approach to myositis pain and open the door to phenotype-directed treatment strategies — a potential game-changer for patients whose pain is often undertreated or misattributed solely to muscle inflammation.